Ju J, Li Z, Liu J, Peng X, Gao F
Int J Mol Sci. 2025; 26(5).
PMID: 40076488
PMC: 11899445.
DOI: 10.3390/ijms26051862.
Aldawod H, Patel A, Emara R, Liang D, Ho J, Amin T
Nat Commun. 2025; 16(1):686.
PMID: 39848946
PMC: 11758388.
DOI: 10.1038/s41467-025-55945-4.
Gomes I, Gupta A, Margolis E, Fricker L, Devi L
Mol Pharmacol. 2024; 106(5):240-252.
PMID: 39187388
PMC: 11493337.
DOI: 10.1124/molpharm.124.000947.
Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S
Signal Transduct Target Ther. 2024; 9(1):88.
PMID: 38594257
PMC: 11004190.
DOI: 10.1038/s41392-024-01803-6.
Gao L, Zhang Z, Zhu Y, Lu X, Tian Y, Wei L
BMC Anesthesiol. 2024; 24(1):116.
PMID: 38528479
PMC: 10964693.
DOI: 10.1186/s12871-024-02501-0.
Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation.
Grudzien P, Neufeld H, Ebe Eyenga M, Gaponenko V
Front Immunol. 2023; 14:1184014.
PMID: 37575219
PMC: 10420067.
DOI: 10.3389/fimmu.2023.1184014.
Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors.
Fouillen A, Bous J, Granier S, Mouillac B, Sounier R
Membranes (Basel). 2023; 13(6).
PMID: 37367810
PMC: 10303988.
DOI: 10.3390/membranes13060606.
Significance of music therapy in treating depression and anxiety disorders among people with cancer.
Eseadi C, Ngwu M
World J Clin Oncol. 2023; 14(2):69-80.
PMID: 36908676
PMC: 9993142.
DOI: 10.5306/wjco.v14.i2.69.
Coordinated activity of a central pathway drives associative opioid analgesic tolerance.
Hou Y, Zou G, Wang X, Guo H, Ma X, Cheng X
Sci Adv. 2023; 9(6):eabo5627.
PMID: 36753548
PMC: 9908028.
DOI: 10.1126/sciadv.abo5627.
Opioid signaling and design of analgesics.
Paul B, Sribhashyam S, Majumdar S
Prog Mol Biol Transl Sci. 2023; 195:153-176.
PMID: 36707153
PMC: 10325139.
DOI: 10.1016/bs.pmbts.2022.06.017.
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward.
Gamble M, Williams B, Singh N, Posa L, Freyberg Z, Logan R
Front Syst Neurosci. 2022; 16:1059089.
PMID: 36532632
PMC: 9751598.
DOI: 10.3389/fnsys.2022.1059089.
Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham J, Markovic T, Massaly N, Moron J
Front Syst Neurosci. 2022; 16:1014768.
PMID: 36341476
PMC: 9628214.
DOI: 10.3389/fnsys.2022.1014768.
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
Yamaguchi M, Miyano K, Hirayama S, Karasawa Y, Ohshima K, Uezono E
Molecules. 2022; 27(20).
PMID: 36296658
PMC: 9611050.
DOI: 10.3390/molecules27207065.
Chemoenzymatic Synthesis of Optically Active Ethereal Analog of -Moramide-A Novel Potentially Powerful Analgesic †.
Borowiecki P
Int J Mol Sci. 2022; 23(19).
PMID: 36233106
PMC: 9569485.
DOI: 10.3390/ijms231911803.
Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl.
Tian X, Zhang J, Wang S, Gao H, Sun Y, Liu X
Front Pharmacol. 2022; 13:919325.
PMID: 36120357
PMC: 9478952.
DOI: 10.3389/fphar.2022.919325.
Sex-specific role of the circadian transcription factor NPAS2 in opioid tolerance, withdrawal and analgesia.
Puig S, Shelton M, Barko K, Seney M, Logan R
Genes Brain Behav. 2022; 21(7):e12829.
PMID: 36053258
PMC: 9744556.
DOI: 10.1111/gbb.12829.
Behavioral, Neural, and Molecular Mechanisms of Conditioned Mate Preference: The Role of Opioids and First Experiences of Sexual Reward.
Quintana G, Mac Cionnaith C, Pfaus J
Int J Mol Sci. 2022; 23(16).
PMID: 36012194
PMC: 9409009.
DOI: 10.3390/ijms23168928.
A Selective Adenylyl Cyclase 1 Inhibitor Relieves Pain Without Causing Tolerance.
Giacoletti G, Price T, Hoelz L, Shremo Msdi A, Cossin S, Vazquez-Falto K
Front Pharmacol. 2022; 13:935588.
PMID: 35899113
PMC: 9310748.
DOI: 10.3389/fphar.2022.935588.
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation.
Coluzzi F, Rullo L, Scerpa M, Losapio L, Rocco M, Billeci D
CNS Drugs. 2022; 36(6):617-632.
PMID: 35616826
PMC: 9166888.
DOI: 10.1007/s40263-022-00924-2.
Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine.
Mizobuchi Y, Miyano K, Manabe S, Uezono E, Komatsu A, Kuroda Y
Biomolecules. 2022; 12(3).
PMID: 35327617
PMC: 8946650.
DOI: 10.3390/biom12030426.